CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Onconova Therapeutics, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. The companys clinical-stage product candidates include Rigosertib IV, which is in Phase III cli...Show all
Company (IPO / Went public)
Phone: 267-759-3680
375 Pheasant Run
Newtown, 18940
Pennsylvania, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Onconova Therapeutics | $165.6M | Jul 25, 2013 |
| KAI Pharmaceuticals | $63M | Apr 11, 2012 |
| MacuSight | $0M | Mar 22, 2021 |
| See all 17 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods and compositions for treatment of cancer | Dec 06, 2013 | Mar 03, 2020 | Patent |
| Formulations with enhanced stability and bioavailability for administantion of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones | Aug 28, 2017 | Oct 16, 2018 | Patent |
| Stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | May 15, 2015 | Jul 25, 2017 | Patent |
| Stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | Mar 24, 2011 | Jun 23, 2015 | Patent |
| Compositions and methods for prevention and treatement of wounds | Mar 24, 2011 | Jun 02, 2015 | Patent |
